| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3577847
Max Phase: Preclinical
Molecular Formula: C3H10O6P2
Molecular Weight: 204.06
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COP(=O)(O)CP(=O)(O)OC
Standard InChI: InChI=1S/C3H10O6P2/c1-8-10(4,5)3-11(6,7)9-2/h3H2,1-2H3,(H,4,5)(H,6,7)
Standard InChI Key: WXOYSNRVHAQVSW-UHFFFAOYSA-N
Associated Targets(Human)
Hydroxyapatite 165 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 204.06 | Molecular Weight (Monoisotopic): 203.9953 | AlogP: 0.61 | #Rotatable Bonds: 4 |
| Polar Surface Area: 93.06 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 1.41 | CX Basic pKa: | CX LogP: -1.26 | CX LogD: -5.87 |
| Aromatic Rings: 0 | Heavy Atoms: 11 | QED Weighted: 0.65 | Np Likeness Score: 0.35 |
References
| 1. Puljula E, Turhanen P, Vepsäläinen J, Monteil M, Lecouvey M, Weisell J.. (2015) Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial esters., 6 (4): [PMID:25893039] [10.1021/ml5004603] |
Source
Source(1):